Bowel cancer screening in England: a qualitative study of GPs' attitudes and information needs by Woodrow, Chris et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Family Practice
Open Access Research article
Bowel cancer screening in England: a qualitative study of GPs' 
attitudes and information needs
Chris Woodrow, Linda Rozmovits, Paul Hewitson, Peter Rose, Joan Austoker 
and Eila Watson*
Address: CRUK-Primary Care Education Research Group, Department of Primary Care, University of Oxford, Oxford, UK
Email: Chris Woodrow - chris.woodrow@dphpc.ox.ac.uk; Linda Rozmovits - linda_rozmovits@sympatico.ca; 
Paul Hewitson - paul.hewitson@dphpc.ox.ac.uk; Peter Rose - peter.rose@dphpc.ox.ac.uk; Joan Austoker - joan.austoker@dphpc.ox.ac.uk; 
Eila Watson* - eila.watson@dphpc.ox.ac.uk
* Corresponding author    
Abstract
Background:  The National Health Service Bowel Cancer Screening Programme is to be
introduced in England during 2006. General Practitioners are a potentially important point of
contact for participants throughout the screening process. The aims of the study were to examine
GPs' attitudes and information needs with regard to bowel cancer screening, with a view to
developing an information pack for primary care teams that will be circulated prior to the
introduction of the programme.
Methods:  32 GPs participated in semi-structured telephone interviews. 18 of these had
participated in the English Bowel Screening Pilot, and 14 had not. Interviews covered attitudes
towards the introduction of the Bowel Cancer Screening Programme, expected or actual increases
in workload, confidence in promoting informed choice, and preferences for receiving information
about the programme.
Results: GPs in the study were generally positive about the introduction of the Bowel Cancer
Screening Programme. A number of concerns were identified by GPs who had not taken part in
the pilot programme, particularly relating to patient welfare, patient participation, and increased
workload. GPs who had taken part in the pilot reported holding similar concerns prior to their
involvement. However, in many cases these concerns were not confirmed through GPs
experiences with the pilot. A number of specific information needs were identified by GPs to enable
them to provide a supportive role to participants in the programme.
Conclusion: The study has found considerable GP support for the introduction of the new Bowel
Cancer Screening Programme. Nonetheless, GPs hold some significant reservations regarding the
programme. It is important that the information needs of GPs and other members of the primary
care team are addressed prior to the roll-out of the programme so they are equipped to promote
informed choice and provide support to patients who consult them with queries regarding
screening.
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Background
Colorectal cancer is the second most common cause of
cancer death in the UK [1]. Evidence from randomized
controlled trials has confirmed that screening for colorec-
tal cancer using Faecal Occult Blood testing (FOBt) as the
primary screening modality can significantly reduce color-
ectal cancer mortality [2]. Two pilot screening rounds,
which commenced in 2000, were implemented in order
to assess the viability of a national screening programme
for bowel cancer being undertaken within the UK
National Health Service. Data from the first pilot round
demonstrated that FOBt screening for colorectal cancer is
feasible within the context of the NHS [3]. A national pro-
gramme of screening is expected to be rolled out in 2006.
The National Health Service Bowel Cancer Screening Pro-
gramme (BCSP) will be centrally organised in England,
with call-recall services and testing and analysis of FOBt
kits performed by five central screening hubs across the
country. If a participant receives a positive FOBt result
they will be offered an appointment with a specialist
nurse to discuss the implications of this at a local screen-
ing centre. GPs will also be notified of the participant's
positive FOBt result. Primary care will not have direct
responsibility for the recruitment or delivery of the pro-
gramme. Therefore, their involvement is likely to be con-
cerned with administrative duties (such as dealing with
letters and reports generated by the screening units) and
providing information to patients who have queries about
the screening process [4].
GPs may be an important source of information for
patients who have queries about bowel cancer screening.
In healthcare systems outside the UK (where primary care
is more directly involved with the screening process), GPs
have been identified as the preferred source of informa-
tion about bowel cancer [5] and the person most influen-
tial in patient's decisions regarding testing [6], with GP
motivation associated with uptake of screening [7]. If GPs
are to effectively provide information to patients with
queries about the screening programme, it is important to
explore their attitudes towards the BCSP. Informed choice
is a central strand to the BCSP, with the National Screen-
ing Committee advising that both the risks and benefits
are made explicit to individuals invited to cancer screen-
ing [8]. GPs could play a role in the facilitation of
informed choice in patients who consult them about par-
ticipating in bowel cancer screening, a task entirely
dependant on the provision of relevant, accurate and
complete information. Therefore, it is also important to
understand the specific information needs of general prac-
titioners involved with bowel cancer screening.
This report describes the findings from qualitative inter-
views conducted with GPs who either had, or had not
been involved in the English Bowel Screening Pilot. The
aims of the study were to examine GPs' attitudes and
information needs with regard to bowel cancer screening,
with a view to developing an information pack for pri-
mary care teams that will be circulated prior to the intro-
duction of the programme.
Methods
Semi-structured telephone interviews with 32 General
Practitioners (GPs) were conducted between April and
June 2005. The sample consisted of both GPs practising in
areas participating in the pilot phase of the BCSP, and GPs
practising outside these areas. This allowed the compari-
son of attitudes and information needs between individu-
als with differing levels of knowledge and experience of
the screening programme. Letters of invitation were sent
to 297 GPs from 93 practices in areas participating in the
pilot phase of the BCSP. Convenience sampling was used
to recruit GPs practising outside these areas. GPs were
remunerated £50 for participation.
Eighteen GPs (13 males and 5 females) were recruited
from 15 practices participating in the pilot phase of the
BCSP. These participants were based in practices located
in the Coventry, Rugby, and North Warwickshire areas of
England, covering locations ranging from rural to inner
city. The majority of participants described their popula-
tions as lower middle to middle class, with a minority
indicating that their practices covered areas of severe dep-
rivation. The majority of GPs indicated that fewer than
10% of their practice populations were from ethnic
minority backgrounds, with three indicating that they had
large Asian populations.
The remaining fourteen GPs (6 males and 8 females) were
recruited from practices in areas that did not participate in
the pilot phase of the BCSP. These individuals were based
in various locations in England, ranging from rural to
inner city. Most participants indicated that their patient
populations were socio-economically mixed, and a small
number indicated that they worked in areas of severe dep-
rivation or relatively affluent areas. Five GPs indicated that
they had substantial or increasing numbers of ethnic
minority patients, largely Asian.
Telephone interviews were conducted by LR, an experi-
enced interviewer. Interviews were tape recorded with the
participant's consent and lasted approximately 20 – 30
minutes. Two semi-structured interview schedules devel-
oped by LR and EW were used for this purpose, one for use
with pilot GPs and one for use with the general popula-
tion GPs. These covered participant's attitudes towards the
introduction of the national bowel cancer screening pro-
gramme, any expected or actual increases in workload,
their confidence in promoting informed choice, and theirBMC Family Practice 2006, 7:53 http://www.biomedcentral.com/1471-2296/7/53
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preferences for receiving information about the pro-
gramme. Interviews were conducted with both groups
until data saturation was reached.
Interviews were transcribed verbatim, with the accuracy of
each recording verified by the interviewer. A coding frame
was constructed and applied using the HyperResearch
software package by LR. Interviews were analysed for
anticipated and emergent themes using a grounded theory
approach [9]. The analysis included searches for discon-
firming evidence. Coding and interpretation of the data
was regularly discussed with EW.
Results
The overall findings are described below in terms of the
main themes that emerged. After each quote is a descrip-
tor indicating whether or not the GP had participated in
the pilot phase of the BCSP, together with an individual
research number.
Attitudes
Strong support for the introduction of a national screen-
ing programme for bowel cancer was shown by many of
the pilot and non-pilot GPs in this study. However, whilst
welcoming the screening programme, a number of GPs
from both groups expressed certain reservations. Reserva-
tions held by Non-pilot GPs fell into three broad themes.
These related to the welfare of participating individuals,
levels of patient participation and increased workload for
primary care. Pilot GPs reported holding similar reserva-
tions prior to their involvement in the programme,
although many reported that during the course of the
pilot these did not materialise.
Positive attitudes
The benefit of early detection, the non invasive nature of
FOB testing, and knowledge of research evidence demon-
strating mortality reductions by FOB testing were cited by
pilot and non-pilot GPs as reasons for their positive atti-
tudes towards the introduction of the BCSP.
"... The basic research underlying it was done years ago ... and
there was absolutely no doubt that it would save lives ... So ...
I'm very positive about it. I think it's long overdue." (NON-
PILOT 11)
"... this is the sort of thing we should be doing ... if there's a
reasonable chance that we can improve detection and treatment
of colorectal cancer then you know it's worth doing ... "(PILOT
3)
In addition to this, many of the pilot GPs commented,
unprompted, on how well the pilot programme had been
run:
"I haven't really had any problems with this pilot at all. I mean
it's been a remarkably smooth introduction" (PCA2)
Reservations
Patient welfare
An issue of concern to a considerable number of non-pilot
GPs was the impact of an increasing culture of screening
on people's lives. Some felt concerned about screening
saturation and the increasing number of interventions
that patients were subjected to:
"... you're sometimes concerned that we're getting to a state
where we're screening this and screening that ..." (NON-
PILOT 13)
The generation of patient anxiety was a concern for many
pilot and non-pilot GPs. Several GPs felt that the possibil-
ity of detecting an abnormality must be weighed off
against potential anxiety generated by the screening proc-
ess:
"... we're already creating a country of worried well and ... we
will add to that because some of the early signs of bowel cancer
are so common ... They'd have to convince me that the faecal
occult test was so good at picking up silent malignancies that it
was worth worrying the life out of the majority of our patients."
(NON-PILOT 12)
A related concern was that of the possibility of patients
taking up FOBt screening without fully realizing the
potential consequences, and dropping out of the process
when offered a colonoscopy:
"I mean if they don't want that [a colonoscopy] then they
shouldn't start, that's the thing. They should live in ignorance
and not start ... and then find that they can't complete it."
(NON-PILOT 10).
The possibility of specific groups of participants being
particularly susceptible to anxiety generated by the screen-
ing programme was also raised. Two non-pilot GPs in par-
ticular felt that the introduction of a new screening
programme had the potential to generate serious anxiety
within their communities. One of these served a large eth-
nic minority population which had little previous experi-
ence of screening, whilst the second was a GP working
with mainly poorly educated manual workers in a com-
munity considered to have unusually high levels of
pathology.
Issues relating to the reliability of the FOB test were also
raised by pilot and non-pilot GPs alike. Of particular con-
cern were anxiety caused by false positive results, false
reassurance derived from normal FOB test results, andBMC Family Practice 2006, 7:53 http://www.biomedcentral.com/1471-2296/7/53
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patients being subjected to (sometimes unwarranted)
invasive procedures through the screening programme.
"I need convincing that the faecal occult test is not going to pro-
duce a lot of false positives that will engender a lot of worry in
people ... I also want to be convinced that we're not going to
then engender a false sense of security ... they start getting firm
symptoms, change of bowel habit, 'But I've had the test done
and it was normal so I won't go."' (NON-PILOT 12).
Some individuals suggested that the possible risks of
screening ought to be made more apparent to potential
participants:
"....patients just see the early pick-up as the end goal ... I think
the false positive, false negative bit of it often passes people by."
(NON-PILOT 5)
Many GPs raised concerns that managing the patient anx-
iety generated by false positives was likely to result in
additional responsibility for GPs, although felt that this
was an inevitable and acceptable part of any screening
programme.
However, whilst around half of pilot GPs were expecting
an increase in consultations with individuals worried by
test results or other aspects of the programme, this did not
seem to be a major issue in practice:
"Well we thought that ... we'd be much more swamped with
false positive patients who'd be frightened and it just didn't
happen." (PILOT 14)
Patient participation
Concerns regarding patient participation in relation to the
screening programme were raised by several non-pilot
GPs. Patient's reluctance to address issues relating to their
bowels was a commonly cited barrier to participation by
GPs:
"I think you're much more likely to get people querying whether
they want to take part in it or not ... because I think people don't
want their bowels looked into thank you very much. I think you
very much get the impression from patients, they'd almost
rather not know ... So I personally think the uptake's going to
be lower and I think that might be a problem for the screening
programme." (NON-PILOT 1)
Furthermore, patients who tended not to be proactive
about their health were felt to be a cause for concern, since
they may not participate in screening. Several GPs felt that
some patients may be disadvantaged because of their age,
incapacity, level of education or English language profi-
ciency:
"... the worry I have is about motivation of the patients to do it.
I mean they're all elderly, some of them will have other disabil-
ities, they may find it difficult to understand the instructions,
difficult to see the point of it, and I feel that ... with the sort of
patients we have ... people who can't read English or people who
aren't very well educated, they're the ones that are going to have
a higher incidence of bowel cancer and they're the ones who are
going to fail to comply ... and not get it done." (NON-PILOT
11)
Similarly, several pilot GPs said they had anticipated
problems with patient participation prior to the pilot.
However, many GPs ultimately reported that during the
course of the pilot they received no indication of low rates
of participation:
"I've not had anyone ... actually come and say 'I don't know
what to do', 'I don't know how to do it', I can't do it, I don't
want to do it' and so on. So I presume that they've either done
it or they've not done it and not told me." (PILOT 12)
One Pilot GP practising in an area of urban deprivation
with a high proportion of ethnic minority (Asian) patients
found that the response rate exceeded expectations:
"... at the beginning I thought they won't be responding because
when you try to screen for cervical cytology among the females
... the response is not very good ... So ... I felt that the response
was pretty good actually by my standards of the practice."
(PILOT 13)
Additional Workload
Most non-pilot GPs envisaged that the introduction of
screening would result in an increase in primary care
workload, with an increase in patient consultations due to
worried individuals seeking information about screening
of concern:
"... the increased workload I think would come largely from
people wanting information or wanting to discuss their results
or wanting reassurance or explanation about the test ... if some-
thing like this is rolled out nationally they will want to come
and talk about it" (NON-PILOT 2)
The quality of patient information provided by the screen-
ing programme was, therefore, considered to be a key fac-
tor in regulating this likely increase in primary care
workload:
"... it depends partly on the quality of ... information that's
given to the public ... I think that's very important, the infor-
mation that goes out to the actual people when they're sent their
letters to take part in the screening and how much the impact
on us, you know ... If that's not clear enough then it will be their
first port of call in terms of queries." (NON-PILOT 1)BMC Family Practice 2006, 7:53 http://www.biomedcentral.com/1471-2296/7/53
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Similarly, ensuring that the information provided to pri-
mary care teams would allow both nurses and reception-
ists to field patient enquiries was considered to be
important in absorbing the anticipated workload:
"... the practice nurses often, you know, people feel most easy
about approaching them with questions about that sort of thing
... I think everybody will need to be informed and able to answer
questions, and you know leaflets and resources around recep-
tion and places like that." (NON-PILOT 5).
However, none of the non-pilot GPs saw the potential
increase in workload as a serious problem, describing this
as an appropriate use of their time. Many expected that the
additional workload would decrease over time as screen-
ing becomes more established, and the public more aware
of the programme. Others felt that additional workload in
the short term would be reduced in the future if screening
leads to earlier diagnosis of bowel cancer and better polyp
surveillance:
Most pilot GPs, like the non-pilot GPs, had anticipated an
increase in workload in terms of increased patient
appointments. Pilot GPs anticipated patient queries from
either patients requiring assistance with completing the
test, or patients who were worried about the screening
process or their results. However, only a small minority of
individuals reported seeing any actual increase in patient
numbers, and GPs reported that queries were usually
included in appointments booked with regard to other
matters. Pilot GPs also considered this to be an appropri-
ate use of their time.
Although patient information leaflets were available in a
variety of languages during the pilot, two GPs whose prac-
tices covered large ethnic minority populations did notice
increase in patient numbers:
"Well I mean there was a fair amount of work involved because
patients would bring all these forms to us and say 'what's this?'
because you know a lot of our Asian patients don't speak English
... So there was more work for us. But I mean I still think it was
worthwhile doing ... in some ways it was a good thing because
we could then impress upon them the importance of doing it ..."
(PILOT 17).
Pilot GPs reported that patients requiring information or
input were usually seeking endorsement of the screening
programme, clarification of how to use the kit, reassur-
ance after a positive FOBt, further details about colonos-
copy, or explanations in languages other than English.
Informed choice and Information needs
Whilst many of the non-pilot GPs held generally positive
attitudes with regard to the screening programme, only a
few individuals indicated that they currently felt able to
promote informed choice in patients who consulted them
about taking part in screening. The majority said that they
would need additional information in order to be able to
achieve this. A description of the entire screening pathway
was commonly cited as a requirement by GPs. Other areas
of information needed to promote informed choice iden-
tified by non-pilot GPs were evidence of the risks and ben-
efits of screening, technical data about the sensitivity and
specificity of FOB testing and evidence of detection and
survival rates.
"I don't have the information at my fingertips about the risk
and benefits ... properly and clearly explained and that's one of
the hardest things, I think, ... in actual clear language."
(NON-PILOT 1)
Most pilot and non-pilot GPs expressed the desire for
accessible statistical information about the screening pro-
gramme to be made available to them in order to fully
inform patients. The use of graphics and charts were cited
as useful inclusions, particularly since these made it easier
to explain complex information to individuals who may
have difficulty understanding verbal information, or who
do not have good English language skills. Similarly, access
to all the information sent to patients by the screening
programme was seen as essential. Many GPs agreed that
future information packs containing both quick reference
elements and more detailed, clinician orientated informa-
tion would best serve the needs of GPs in the provision of
information. GPs expressed the view that quick reference
information would be the most useful item for many GPs.
Many of the pilot GPs had little recollection of the infor-
mation pack provided to them during the course of the
pilot, and indicated that they had used it only rarely.
Rather than any inadequacy with the information, how-
ever, this was largely attributed to the efficiency of the
screening pilot and the briefing sessions GPs had
attended:
"...my recollection is simply that we were primed by face to face
meetings in the first place and therefore were aware, and I don't
necessarily think that the information pack really added much
to that. It was useful as a reference tool, but I mean I don't
think I've even had to refer to it at all." (PILOT 12)
While fully endorsing informed choice as a concept, a
minority of the non-pilot GPs questioned the reality of
promoting it in practice:
"... I think it's absolutely right that we should say that patients
have informed choice but the reality is that they ... would come
to me and say, 'What shall I do doctor?' and they want an
answer from me personally ... quite a lot of patients actuallyBMC Family Practice 2006, 7:53 http://www.biomedcentral.com/1471-2296/7/53
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don't want the information. They can't cope with it. They don't
know what to do with it. Therefore they're looking at you as a
person to sort of say 'What shall I do?' And we then, even
though we may not want this role, have to sort of advise them,
just simplistically." (NON-PILOT 9)
"...we talk about informed choice all the time, but in every
instance we're pushing people to accept essentially the national
guidelines ... as with PSA testing, they're making an informed
choice. But nevertheless we're trying to get them to choose not
to have it done in most cases. And with cervical smears as well
it's an informed choice, but really is there any choice you know?
We're pushing them very very hard to have it done. So the
emphasis is on the informed, not the choice." (NON-PILOT
11)
Discussion
The GPs in this study were generally positive towards the
introduction of the BCSP, regardless of their involvement
in the pilot phase of screening. However, GPs held a
number of reservations with regard to the programme.
Prominent amongst these were concerns for the welfare of
potential screening participants, relating to the impact of
an increasing culture of screening on people's lives, the
potential anxiety caused by the screening process, and
issues with the reliability of the FOB test which may
impact on patients. The need for good information mate-
rials to support the whole primary care team was empha-
sized, as was the importance of quality patient
information. GPs also expressed concerns relating to lev-
els of patient participation in the programme, and the
additional workload which the new programme may gen-
erate for primary care. Both pilot and non-pilot GPs held
similar concerns with regard to the introduction of the
BCSP. However, these concerns were rarely confirmed
through the experience of the pilot GPs.
The study provides a unique qualitative examination of
the attitudes of GPs towards the first new cancer screening
programme to be introduced in England for several years.
The sample included both GPs who have been involved in
the bowel cancer screening pilot and those who have not.
GPs practiced in a range of locations, and with diverse
patient populations. A possible limitation of the study is
the small number of GPs involved, although the vast
majority of GPs came from different practices. Whilst data
saturation was reached, a convenience sample was used to
recruit non-pilot GPs which may have been biased
towards individuals holding positive attitudes regarding
screening for bowel cancer. Furthermore, only a small
number of GPs in the sample reported practising in areas
with large numbers of ethnic minority patients. Ethnic
minority groups were associated with lower levels of par-
ticipation in the pilot [10], and those GPs in the current
sample who did practice in areas with large numbers of
these participants reported increases in patient appoint-
ments. Therefore, further work with GPs such as these,
who may have different experiences with the programme,
is required.
The concerns raised by GPs relating to the welfare of
screening participants are not unique to bowel cancer
screening. UK GPs are generally positive about breast
screening, for example, although hold concerns relating to
pain and discomfort caused by testing, false reassurance
derived from results, and problems caused by false posi-
tive results [11]. Evidence from outside the UK healthcare
system has also highlighted GPs' concerns with screening
for Bowel Cancer (although primary care involvement in
screening differs in countries outside the UK). Family
Doctors in one Canadian study reported rarely using FOB
testing for screening due to a number of serious limita-
tions, including low yield, high rates of false positives and
false negatives, and a number of technical problems [12].
Similarly, only 38% of GPs in an Australian survey study
indicated the belief that FOB testing was an effective
means of reducing premature death from bowel cancer
[13].
The GPs in this study highlighted the importance of the
provision of high quality information to all parties
involved in the National Health Service Bowel Cancer
Screening Programme – both health professionals and
patients. The significance of providing evidence based
information to support GPs and promote shared decision
making in bowel cancer screening has been highlighted
elsewhere [12,13], and in the UK, primary care teams are
provided with detailed information to assist in providing
information to patients on the risks and benefits of the
PSA test as part of the Prostate Cancer Risk Management
Programme [14]. The provision of high quality informa-
tion to patients is similarly important in decision making
regarding screening, and decision aids can increase knowl-
edge and reduce decisional conflict in individuals decid-
ing whether or not to participate in screening [15].
Informed choice is a central theme of the new screening
programme [8], and whilst GPs in the current study indi-
cated that they would be willing to promote informed
choice amongst potential screening participants, they
stressed that their own information needs must first be
addressed. It is important that information materials for
primary care are matched to GPs information preferences.
The most important factor for many GPs related to ease of
use on a day to day basis. Concise information that can be
quickly digested by GPs, understood by patients, and used
by all members of the primary care team would maximise
the efficiency of information provision to potential
screening participants. Similarly, whilst GPs accepted that
managing patient anxiety is an acceptable use of their
time, a number felt that the risks of screening ought to beBMC Family Practice 2006, 7:53 http://www.biomedcentral.com/1471-2296/7/53
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made more apparent to potential participants at the out-
set. GPs felt that the provision of high quality information
to patients would promote understanding of the risks and
benefits of screening, and may therefore help to alleviate
some of the potential problems experienced by patients.
This in turn could alleviate some of the additional work-
load impact on the GPs themselves.
GPs and other members of the primary care team will not
be directly involved in organisational aspects of the BCSP,
although they are a potentially important point of contact
for patients with queries relating to any stage of the
screening process. Pilot GPs in this study did not report
large numbers of additional appointments, reflecting the
"modest but discernable" increase reported in a previous
survey and audit of practices participating in the pilot [4].
However, survey data from the first round of the screening
pilot indicated that a significant proportion of individuals
with positive test results and screen-detected cancers con-
sulted their GPs [10], and it is inevitable that there will be
some increase in patient queries during the roll out of the
programme. Therefore, the support of primary care will be
important for the new programme. It is interesting to note
that whilst pilot GPs reported rarely meeting worried
patients and surprise at the apparent high level of partici-
pation, data from the first round of the screening pilot
indicates that overall uptake was 59% in England, with
uptake lowest in areas with the highest proportion of res-
idents from the Indian-subcontinent [10]. Indeed, the
GPs in the current sample with significant numbers of eth-
nic minority patients proved to be an exception in that
they did experience significant increases in patient consul-
tations, reporting that they were happy to be in a position
to assist these individuals. When the national programme
commences, primary care may be well placed to assist in
providing information and support to hard to reach
groups with special needs, such as those with poor English
language skills, complications caused by pre existing med-
ical conditions, or unusually high levels of anxiety.
It is also important to note that pilot enjoyed particularly
high standards of efficiency, which compelled a number
of GPs to comment unprompted on how well it had been
run. The pilot GPs in our study rarely reported using the
educational materials provided to them. The main reason
cited for this was the exceptional quality of briefing ses-
sions, and the high level of support provided both to pri-
mary care and to patients by the screening team. If this
quality is not maintained, therefore, then the provision of
high quality information will be of greater significance
both to primary care and to patients during the pro-
gramme itself than during the pilot.
Conclusion
In conclusion, this study has found considerable GP sup-
port for the introduction of the new Bowel Cancer Screen-
ing Programme. Nonetheless, GPs hold some significant
reservations about the programme. Education prior to the
start of the programme and regular feed-back once the
programme is up and running are essential to ensure pri-
mary care support. The findings from this study have
informed the development of an information pack for pri-
mary care teams that will be circulated prior to the intro-
duction of the programme.
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